
Materials · Fertilizers & Agricultural Chemicals
$80.92
-0.11%
Vol: 2.2M
Friday, May 1, 2026
Corteva will release first quarter 2026 earnings on May 5, 2026 after market close, with analyst expectations of $1.14 EPS and $4.65 billion in revenue. The company declared a quarterly dividend of $0.18 per share and confirmed its planned separation into two listed companies (New Corteva and SpinCo) will occur in the fourth quarter of 2026. Luke Kissam has been named CEO of New Corteva as part of the transition.
Corteva announced executive leadership teams for both future entities from its planned Q4 2026 separation. Luther Kissam appointed CEO of New Corteva (crop protection company), joining June 1 as current crop protection CEO. Current CEO Chuck Magro and CFO David Johnson moving to SpinCo roles. Jeff Rudolph named CFO of New Corteva, with Brook Cunningham as Chief Commercial Officer and Ralph Ford as Chief Integrated Operations Officer. Q1 earnings expected May 5 with $1.14 EPS and $4.65 billion revenue. RBC raised price target to $95 from $89 on April 24; Wells Fargo raised to $90 from $85 on April 21.
Corteva Inc announced executive leadership for planned separation in Q4 2026 into two publicly-traded companies: 'New Corteva' (crop protection) led by Luke Kissam as CEO starting June 1, and 'SpinCo' (advanced seed and genetics). Current CEO Chuck Magro and CFO David Johnson will transition to SpinCo leadership. Q1 2026 earnings expected May 5. Board authorized $0.18 quarterly dividend. Company planning $15 million investment in Ukrainian seed production.
Corteva announced Luther Kissam (ex-Albemarle CEO) as chief executive of 'New Corteva,' the future standalone crop protection company, starting June 1 ahead of Q4 2026 separation. Complete executive team named for New Corteva (CFO Jeff Rudolph, CCO Brook Cunningham, CIOO Ralph Ford, CTO Reza Rasoulpour). Current CEO Chuck Magro to lead SpinCo (seed/genetics company) with SpinCo team named. SpinCo investor day scheduled September 15 at NYSE. UBS raised price target to $88 from $80, maintaining Neutral rating.
Corteva Inc. revealed key leadership appointments on April 14, 2026, ahead of its planned two-way separation in Q4 2026. Luther Luke Kissam, former Albemarle CEO, was named CEO of New Corteva, the crop protection company, joining June 1, 2026. Current CEO Chuck Magro will lead SpinCo, the seed and genetics company. SpinCos executive team includes David Johnson (CFO), Judd OConnor (Chief Commercial and Operations Officer). New Corteva plans an investor day on September 15 at NYSE.
Corteva (CTVA) announced a planned separation of its seeds business in late 2026, transforming into a pure-play crop protection company. The company will host dual Investor Days on September 15, 2026 at NYSE featuring separate sessions for seed/genetics and the new post-separation Corteva. Q1 2026 earnings scheduled for May 5, 2026 after market close. Robeco Institutional Asset Management grew its stake 36.4% while Factory Mutual Insurance reduced its position 44%.
Corteva delivered strong results with stock up 9.5% in past month and 21.7% over 3 months, driven by four consecutive quarterly earnings beats. The company's innovation pipeline enables premium pricing and improved margins. Major institutional shift: Trium Capital acquired 14,016 shares while Factory Mutual reduced position 44% in Q4. Corteva plans to spin off seeds division in late 2026, becoming pure-play crop protection company.
U.S. appeals court dismissed antitrust claims against Corteva and peers (Syngenta, Bayer, BASF) for failing to provide sufficient evidence of price-fixing collusion. Corteva announced shareholder virtual meeting for April 28 to approve tax-free separation into two companies by end of 2026. CEO Chuck Magro will lead seed business SpinCo; Chair Greg Page will lead crop protection New Corteva. EBITDA reached $3.9B in 2025 (up 14% YoY) with 7% growth guidance for 2026.
Corteva Inc. stock reached a new 52-week high of $85.56 on April 6-7, 2026, reflecting strong 45% EPS growth over the past year. Argus raised price target from $80 to $91 with Buy rating on April 6, while Citi raised to $83 from $80. Company plans late 2026 seeds business spinoff to become pure-play crop protection company. FY 2026 guidance set at 3.450-3.700 EPS, balancing mixed sentiment on insider selling with strong valuation metrics and agricultural growth potential.
Corteva reaches all-time high, surpassing $84 mark, trading at $85.04. Argus raised price target to $91 from $80 with Buy rating. Company plans to spin off seeds business in late 2026 to become pure-play crop protection firm. Consensus target $75.28 with mixed insider activity.
Corteva plans dual Investor Days September 15 at NYSE showcasing seed/genetics business as prospective standalone public company and 'New Corteva' post-separation. Argus analyst raised price target to $91 from $80 with Buy rating March 31. 2026 guidance: $4.0-$4.2B operating EBITDA, $3.45-$3.70 operating EPS. 13 analysts consensus Buy. Stock at $84.25 down 1.4% on light insider selling concerns.
Corteva announced planned separation of seed and genetics business in late 2026, transforming into pure-play crop protection company. Corteva scheduled investor days for September 15, 2026 to present seed business as standalone public company ("SpinCo") at 9 AM EDT and new Corteva vision at 1 PM EDT. Argus raised price target to $91 from $80 (Buy). Citi raised target to $83 from $80. Berenberg Bank maintains Hold. Stock price at $85.67 (up 4.12% weekly, up 8.09% monthly, up 35.24% annually). Analyst rating consensus remains cautious amid agricultural sector headwinds but optimistic on innovation potential in crop protection and advanced seeds. Valuation reflects both near-term challenges and long-term separation upside.
Corteva's Board unanimously approved a plan to separate into two independent publicly traded companies: New Corteva (Crop Protection, estimated 2025 net sales $7.8B) and SpinCo (Seed, estimated 2025 net sales $9.9B). Separation targeted for H2 2026. Argus raised price target to $91 from $80 (Buy) and Citi raised target to $83.
Corteva guides FY 2026 EPS of $3.45-$3.70; Argus upgrades to Buy with $91 target ahead of seeds spinoff in late 2026.
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| CTVACORTEVA | $80.92 | -0.11% | -3.9% | 20.0x | 0.68 | $54.4B |
| CFCF | $123.00 | -0.97% | -5.2% | 12.8x | 0.52 | $19.1B |
| MOSMOSAIC | $23.19 | -0.37% | -12.2% | 9.6x | 0.96 | $7.4B |
| LINLINDE | $508.66 | +1.50% | +0.3% | 25.7x | 0.79 | $232.2B |
| NEMNEWMONT | $108.91 | -1.96% | -1.5% | 9.8x | 0.47 | $118.6B |
| FCXFREEPORT | $56.78 | -1.74% | -5.4% | 15.7x | 1.47 | $82.9B |
Price above both MAs — bullish structure.